Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forced fluid removal vs. usual care in ICU patients with high-risk acute kidney injury and severe fluid overload (FFAKI)
2015-001701-13Phase 4Terminated
- Sponsor
- Nordsjællands Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of furosemide in acute kidney failure (AKF) and hypervolemia (2 arms), sponsored by Nordsjællands Hospital. Primary endpoint: Cumulative fluid balance at day 5. Started Jul 2015; status: terminated.
02
Drugs
furosemide
03
Conditions
acute kidney failure (AKF)hypervolemia
Beyond the preview
Go deeper on 2015-001701-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001701-13.